» Articles » PMID: 34192216

The Global Impact of COVID-19 on Infertility Services

Overview
Specialty Public Health
Date 2021 Jun 30
PMID 34192216
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The COVID-19 pandemic has posed unique concerns and potential risks to women now pregnant or considering childbearing. Although no professional societies have issued recommendations that women avoid conception at this time, several professional organizations recommended a moratorium on infertility services including both medically assisted reproduction and assisted reproductive technology shortly after the World Health Organization declared COVID-19 infection to be a pandemic. Reasons cited for undertaking these extraordinary measures included prevention of possible complications of assisted reproductive technology and medically assisted reproduction and virus induced complications of pregnancy including potential vertical transmission to the fetus and optimization use of critical health care resources. A survey of reproductive health providers in 97 countries was undertaken to assess their response to the pandemic and recently issued guidance. Although different countries reacted differently with diverse responses and variable resources, the results suggest that the reproductive health community has largely been responsive to public health and individual patient concerns.

Citing Articles

A multi-faceted exploration of unmet needs in the continuing improvement and development of fertility care amidst a pandemic.

Augustyniak M, Coticchio G, Esteves S, Kupka M, Hong C, Fincham A Int Braz J Urol. 2024; 50(5):631-650.

PMID: 39059016 PMC: 11446562. DOI: 10.1590/S1677-5538.IBJU.2024.9915.


The influence of lifestyle interventions and overweight on infertility: a systematic review, meta-analysis, and meta-regression of randomized controlled trials.

Sustarsic A, Hadzic V, Meulenberg C, Abazovic E, Videmsek M, Burnik Papler T Front Med (Lausanne). 2023; 10:1264947.

PMID: 38020109 PMC: 10646477. DOI: 10.3389/fmed.2023.1264947.


Main topics in assisted reproductive market: A scoping review.

Aderaldo J, Rodrigues de Albuquerque B, Camara de Oliveira M, de Medeiros Garcia Torres M, Lanza D PLoS One. 2023; 18(8):e0284099.

PMID: 37527215 PMC: 10393141. DOI: 10.1371/journal.pone.0284099.


SARS-CoV-2, fertility and assisted reproduction.

Ata B, Vermeulen N, Mocanu E, Gianaroli L, Lundin K, Rautakallio-Hokkanen S Hum Reprod Update. 2022; 29(2):177-196.

PMID: 36374645 PMC: 9976972. DOI: 10.1093/humupd/dmac037.


The impact of COVID-19 mitigation measures on fertility patients and clinics around the world.

Cutting E, Catt S, Vollenhoven B, Mol B, Horta F Reprod Biomed Online. 2022; 44(4):755-763.

PMID: 35190253 PMC: 8712431. DOI: 10.1016/j.rbmo.2021.12.016.


References
1.
Rasmussen S, Jamieson D, Honein M, Petersen L . Zika Virus and Birth Defects--Reviewing the Evidence for Causality. N Engl J Med. 2016; 374(20):1981-7. DOI: 10.1056/NEJMsr1604338. View

2.
Veiga A, Gianaroli L, Ory S, Horton M, Feinberg E, Penzias A . Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE and IFFS. Hum Reprod Open. 2020; 2020(3):hoaa033. PMC: 7357170. DOI: 10.1093/hropen/hoaa033. View